Capital Investment Advisory Services’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Capital Investment Advisory Services’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,900	Closed	-$45K	–	1512
2019 Q2	$45K	Buy	2,900 +2,000	+222%	+$19K	0.01%	579
2019 Q1	$8K	Hold	900	–	–	﹤0.01%	895
2018 Q4	$7K	Buy	+900	New	+$14.5K	﹤0.01%	891

Other funds holding DOVA

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Investment Advisory Services's DOVA Position: Q3 2019 in Review

Capital Investment Advisory Services sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q3 2019, closing a stake of 2,900 shares — an estimated $45K sold.

Capital Investment Advisory Services first reported a position in DOVA in Q4 2018 and held it in 3 quarters. The position peaked at $45K in Q2 2019. 72 funds tracked by Wall St. Rank hold DOVA as of Q3 2019.

Capital Investment Advisory Services reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Capital Investment Advisory Services sold 2,900 Dova Pharmaceuticals, Inc. Common Stock shares in Q3 2019, an estimated $45K.
Capital Investment Advisory Services first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 3 quarters.
Capital Investment Advisory Services's Dova Pharmaceuticals, Inc. Common Stock position peaked at $45K in Q2 2019.
72 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on Capital Investment Advisory Services's 13F filing for Q3 2019, filed 17 Oct 2019.